University · founded 1919

Kettering University

Flint, United States · kettering.edu

Manage this page

Citations, last 5 years: 2 490
Works, last 5 years: 440
h-index: 112
Scientists listed: 28
Grants since 2016: 3 213

Grants received

2018–2023 · career development · K08

Role of the Cohesin complex in normal and malignant hematopoiesis

Aaron D Viny · Kettering University · funded by National Institutes of Health

$256.8kGenomics and Chromatin Dynamics

2018–2025 · research · R35

Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability

Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health

$1M

2018–2023 · research · R01

The role of intestinal microbiota in graft-versus-host disease

Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health

$539.2kGut microbiota and health

2018–2020 · career development · K99

Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment

Elham Azizi · Kettering University · funded by National Institutes of Health

$134.6kSingle-cell and spatial transcriptomics

2018–2023 · research · R35

Mechanisms of DNA and RNA transactions

Stewart H Shuman · Kettering University · funded by National Institutes of Health

$1.1M

2018–2021 · fellowship · F32

Creating a targeted micropharmacy for improved cellular cancer therapies

Thomas J Gardner · Kettering University · funded by National Institutes of Health

$61.6kCAR-T cell therapy research

2018–2024 · cooperative agreement · U01

Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer

Jason S. Lewis · Kettering University · funded by National Institutes of Health

$688.4k

2018–2023 · grant · DP5

The role of chromosomal instability in tumor evolution

Samuel F Bakhoum · Kettering University · funded by National Institutes of Health

$449k

2018–2023 · research · R01

DOTA-based pre-targeting of alpha emitters

Sarah Marie Cheal · Kettering University · funded by National Institutes of Health

$717.7kRadiopharmaceutical Chemistry and Applications

2018–2023 · grant · Standard Grant

MRI: Acquisition of a Fluorescence Microscopy System for Research and Teaching at Kettering University

Ronald Kumon · Kettering University · funded by National Science Foundation

$251.3k

2018–2019 · career development · K99

Understanding the developmental mechanisms that ensure robustness in neuronal patterning

Pavak Kirit Shah · Kettering University · funded by National Institutes of Health

$118.1kGenetics, Aging, and Longevity in Model Organisms

2018–2023 · research · R01

Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening

Lisa Carter-Bawa · Kettering University · funded by National Institutes of Health

$399.1k

2018–2023 · research · R50

Exploiting tumor metabolism to optimize T cell therapy

Inna Serganova · Kettering University · funded by National Institutes of Health

$218.2k

2018–2023 · research · R01

Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria

Derek S Tan · Kettering University · funded by National Institutes of Health

$1.5M

2018–2023 · research · R01

Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening

Lisa Carter-Bawa · Kettering University · funded by National Institutes of Health

$489.3k

2018–2024 · research · R01

Histopathologic validation of 89Zr-DFO-HuMab-5B1 PET/CT imaging in CA 19-9 positive pancreatic cancer

Michael I D'Angelica · Kettering University · funded by National Institutes of Health

$398.5k

2018–2023 · career development · K08

Investigating L1CAM-dependent stem cell regeneration in metastasis

Karuna Ganesh · Kettering University · funded by National Institutes of Health

$256.8k

2018–2022 · research · R01

Biomechanical control of inflammation by the nuclear membrane

Philipp Michael Niethammer · Kettering University · funded by National Institutes of Health

$404.1k

2018–2023 · research · R01

Mechanisms driving cell fate specification and morphogenesis in the blastocyst

Anna-Katerina Hadjantonakis · Kettering University · funded by National Institutes of Health

$489.1k

2018–2023 · research · R01

Defining mechanisms of resistance to hormonal therapy in breast cancer

Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health

$410.8k

2018–2023 · program · P50

SPORE in Soft Tissue Sarcoma

Samuel Singer · Kettering University · funded by National Institutes of Health

$2.2MSarcoma Diagnosis and Treatment

2018–2023 · research · R01

Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK

Rona Yaeger · Kettering University · funded by National Institutes of Health

$505kMelanoma and MAPK Pathways

2018–2023 · research · R01

Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis

Daniel Bachovchin · Kettering University · funded by National Institutes of Health

$429.3kInflammasome and immune disorders

2018–2022 · research · R01

Alloreactive and autoreactive immune-mediated mechanisms of impaired epithelial regeneration in the GI tract

Alan M Hanash · Kettering University · funded by National Institutes of Health

$638.5k

2018–2022 · research · R01

Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening

Lisa Carter-Bawa · Kettering University · funded by National Institutes of Health

$22.7k

2018–2023 · research · R01

The role of intestinal microbiota in graft-versus-host disease

Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health

$550.2kGut microbiota and health

2018–2023 · research · R01

Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria

Derek S Tan · Kettering University · funded by National Institutes of Health

$1.2M

2018–2023 · program · P50

SPORE in Bladder Cancer

Dean F. Bajorin · Kettering University · funded by National Institutes of Health

$2.2MBladder and Urothelial Cancer Treatments

2018–2028 · research · R01

Discriminating EGFR function in T cells and epithelium during immune-mediated tissue damage

Alan M Hanash · Kettering University · funded by National Institutes of Health

$772.3k

2018–2025 · research · R35

Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability

Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health

$1M

2018–2022 · research · R01

Assessment of sensory gating, attention, and executive control in breast cancer

Tim Alan Ahles · Kettering University · funded by National Institutes of Health

$691.8kCancer-related cognitive impairment studies

2018–2023 · research · R01

Mechanisms driving cell fate specification and morphogenesis in the blastocyst

Anna-Katerina Hadjantonakis · Kettering University · funded by National Institutes of Health

$499.1k

2018–2019 · research · R01

Mechanisms of error-free cell division after whole-genome doubling

Prasad V Jallepalli · Kettering University · funded by National Institutes of Health

$76.2kMicrotubule and mitosis dynamics

2018–2024 · research · R01

Defining mechanisms of resistance to hormonal therapy in breast cancer

Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health

$402.6k

2018–2023 · research · R01

Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors

Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health

$410.8kCAR-T cell therapy research

2018–2021 · fellowship · F32

INVESTIGATING THE MOLECULAR BASIS OF OLAPARIB RESISTANCE IN BRCA2-DEFICIENT PROSTATE CANCER

Kyrie Jean Pappas · Kettering University · funded by National Institutes of Health

$61.2kPARP inhibition in cancer therapy

2018–2025 · research · R35

Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability

Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health

$985.9k

2018–2023 · research · R01

Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors

Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health

$398.5kCAR-T cell therapy research

2018–2025 · research · R35

Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability

Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health

$895.6k

2018–2022 · research · R21

Probing the physiological function of oxo-eicosanoid signaling by intravital imaging in a zebrafish infection model

Philipp Michael Niethammer · Kettering University · funded by National Institutes of Health

$265.4kZebrafish Biomedical Research Applications